5-Dec-2016 Médecins Sans Frontières
MSF press release: RCEP trade deal negotiators must reject terms that would harm access to medicines
International medical humanitarian organisation Médecins Sans Frontières (MSF), along with other health groups, reiterated concerns about harmful intellectual property provisions in the proposed agreement that would increase market monopolies for pharmaceutical corporations and delay or block access to affordable generic medicines.
CETA drug-patent extension applies only to new products, and higher costs are likely at least 8 years away
22-Nov-2016 Huffington Post
Experts have been warning for years that Canada’s trade deal with the European Union would add billions to the cost of pharmaceuticals in Canada, but the government itself apparently did not study the issue.
8-Nov-2016 Pharma in Focus
US reports that data exclusivity for biologics in Australia could still be extended to 12 years via the TPP trade deal have got local activists up in arms.
25-Oct-2016 Newstalk ZB
The Public Health Association (PHA) is asking the NZ government to step in and help our neighbouring countries negotiate better deals for life-saving medicines.
21-Oct-2016 Hindu Business Line
India and the US continued to differ on the issue of intellectual property rights (IPR) norms in their bilateral trade and investment policy discussions
20-Oct-2016 Bangkok Post
Access to affordable medicine and farmers’ control over seeds could be undermined by the Regional Comprehensive Economic Partnership being negotiated between Asean member countries and six other trade partners, says FTA Watch in Thailand
18-Oct-2016 El País
El tratado de libre comercio con Chile que se firmó la semana pasada establece la necesidad de que Uruguay adhiera al Tratado de Cooperación de Patentes (PCT).
An open letter to the sixteen governments negotiating the Regional Comprehensive Economic Partnership (RCEP)
95 health, community and development organisations in the Asia Pacific region call on trade negotiators from sixteen countries in the Regional Comprehensive Economic Partnership agreement negotiations to ensure access to medicines is protected. We the undersigned organisations call on negotiators to protect health and reject all TRIPS plus intellectual property measures in the RCEP.
13-Oct-2016 Don’t trade our lives away
Open letter to ambassadors (in India) of RCEP negotiating countries by Delhi Network of Positive People
Member countries must consider the impact of RCEP on access to medicines in developing countries
11-Oct-2016 South China Morning Post
Affordable generics have transformed medical treatment, yet intellectual property provisions in a China-led regional trade deal could block access to life-saving drugs for millions in Africa and Asia
7-Oct-2016 La Diaria
Uruguay: TLC con Chile propone adherir a un tratado sobre patentes que encarecería la producción de medicamentos genéricos
El Ministerio de Relaciones Exteriores hizo público ayer el texto del Tratado de Libre Comercio (TLC) entre Uruguay y Chile. El acuerdo será sometido en los próximos días a consideración del Parlamento.
5-Oct-2016 Common Dreams
’Unfortunately, trade agreements have become one more mechanism for drug corporations to expand their monopoly power’
28-Sep-2016 Corporate Europe Observatory
Big Pharma is everything but shy when it comes to lobbying EU policy-makers. But what exactly are these groups lobbying for in TTIP?
According to the Bloomberg, Senator Hatch said “They’re going to have to find a way of having the countries agree to change that formality in the TPP to 12 years…If Australia wants to be part of it, they have to meet our terms,”
15-Aug-2016 The Hindu
As the next round of Regional Comprehensive Economic Partnership (RCEP) trade talks begin in Vietnam, humanitarian aid organisation Médecins Sans Frontières calls for the removal of intellectual property provisions from the agreement
11-Aug-2016 Perú 21
Quedó en manos del nuevo Congreso determinar si Perú participará o no del Tratado de Asociación Transpacífico (TPP), el cual es promovido por Estados Unidos e incluye a otros once países.
Provisions related to evergreening of patents in the proposed Regional Comprehensive Economic Partnership Agreement (RCEP) was dropped after stiff opposition from India, Parliament was informed today.
22-Jul-2016 Diario UNO
Ejecutivo lo remitió para su debate, pero críticos advierten que traería solo perjuicios al país y nada adicional a los tratados comerciales ya suscritos.
Adopting a national pharmacare program would offset the higher drug prices expected with the ratification of the Trans-Pacific Partnership, write Tanishq Suryavanshi and Jake Hirsch-Allen.